Skip to main content
Equibles

MORGAN STANLEY

Position in CLDI — Calidi Biotherapeutics, Inc.

CIK 895421 NEW YORK, NY
Back to CLDI Full portfolio

Position in CLDI

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,251
-$11 QoQ
Shares Held
828
+39.9% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 23 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in CLDI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,661,229 across 524 Biotechnology names. CLDI ranks #453 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in CLDI

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,251 13,244
2026-03-31 $2,262 9,467
2025-12-31 $1,716 1,467
2025-09-30 $588 387
2025-06-30 $441 1,919
2025-03-31 $1,142 2,019
2024-12-31 $2,897 2,520
2024-09-30 $2,301 2,019
2024-06-30 $3,837 19,187
2024-03-31 $10,840 19,187
2023-12-31 $28,972 19,187